STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

Objectives This study aims to examine the capacity of anti-Müllerian hormone (AMH) to
predict cumulative live birth rate (CLBR) following IVF/ICSI within 36 months since start of …

Objectives To investigate the association between anti-Müllerian hormone (AMH), a well-
established marker of the ovarian reserve, and time-to-pregnancy (TTP) in natural …

STUDY QUESTION Is a low (< 1.0 μg/L) or moderately low (1.0–1.9 μg/L) serum anti-
Müllerian hormone (AMH) level a risk factor for early pregnancy loss in IVF/ICSI with a fresh …

Objectives The aim was to evaluate the association between serum Anti-Müllerian Hormone
(AMH) level and cumulative live birth rates (LBR) in patients undergoing their first in vitro …

Purpose To update the evidence of anti–müllerian hormone (AMH) as predictive factors for
live birth outcome in women undergoing assisted conception and discover the modulating …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

Objective To determine whether serum anti-Müllerian hormone (AMH) level is a predictor of
clinical pregnancy in women trying to achieve a natural conception. Methods The PubMed …

Objective To investigate whether serum antimüllerian hormone (AMH) levels are
independently related to miscarriage rates after in vitro fertilization–embryo transfer (IVF-ET) …

This single-centre retrospective observational study was performed at a university IVF
centre. The aim was to examine the predictive power of AMH concentrations for clinical …